Metabolic illnesses change ACE2 articulation and increment COVID-19 seriousness Kumar Jeetendra | June 9, 2020 As the COVID-19 pandemic keeps on causing sickness and take lives over the world, plainly the infection influences distinctive populace fragments divergently. Another examination distributed on the preprint server medRxiv* in June 2020 reports that one instrument for this variable seriousness is the differential articulation of the ACE2 receptor in different metabolic conditions, along these …
Fat cell hormone upgrades helpful capability of MSC treatment Kumar Jeetendra | July 12, 2020 Mesenchymal stem cells (MSCs) have the potential to differentiate into a range of different cell types, including bone, fat, and muscle cells. But it’s their ability to stimulate the repair of damaged tissue that has captured the interest of researchers worldwide, with MSCs demonstrating therapeutic effects in the treatment of conditions such as heart disease, …
CBD could lessen lung harm brought about by COVID-19 Kumar Jeetendra | October 19, 2020 One way CBD appears to reduce the”cytokine storm” that damages the lungs and kills many individuals with COVID-19 is by enabling an increase in levels of a natural peptide called apelin, which is proven to reduce inflammation and whose levels are dramatically reduced in the face of this storm. Dental College of Georgia and Medical …
Polypill in addition to headache medicine and polypill alone reduced cardiovascular sickness hazard Kumar Jeetendra | November 17, 2020 A single, daily pill combining blood pressure and cholesterol medications, as well as the addition of a daily dose of aspirin, reduced cardiovascular disease events in people at risk for heart disease, according to late-breaking study presented today in a late-breaking clinical trial presentation at the American Heart Association’s Scientific Sessions 2020. The virtual conference, …
Skin may assist with foreseeing future heart issues Kumar Jeetendra | December 17, 2020 Our skin informs us when we have spent too much time in sunlight or when the dry air of winter has sucked away too much moisture. Now Jefferson researchers find that the skin may also foretell problems unrelated to the protective barrier. An international group of researchers headed by Jouni Uitto, MD, PhD, a Professor …
Smoking traditional cigarettes alongside e-cigarettes causes harmful wellbeing impacts Kumar Jeetendra | January 4, 2021 Smoking traditional cigarettes in addition to using e-cigarettes leads to harmful health effects like smoking cigarettes exclusively, according to new research published today in the American Heart Association’s flagship journal Circulation. Smoking, a well-known link to cardiovascular disease and death, seems to be on the decline. While using e-cigarettes, known as vaping, is increasingly popular, …
Hydrogel injection could help fix harm to the heart muscle after heart attack Kumar Jeetendra | February 19, 2021 Researchers at CÚRAM, the SFI Research Centre for Medical Devices based at NUI Galway, and BIOFORGE Lab, at the University of Valladolid in Spain, have developed an injectable hydrogel which might help repair and prevent additional damage to the heart muscle following a heart attack occasion. The results of their research have only been published …
First smart speaker for contactless observing of both reguilar and unpredictable heartbeats Kumar Jeetendra | March 9, 2021 Wise speakers, such as Amazon Echo and Google Home, have proven adept at monitoring certain health care issues at home. By way of instance, researchers at the University of Washington have shown that these devices can detect cardiac arrests or track babies breathing. But what about monitoring something even smaller: the moment motion of individual …
FDA supports new medication for therapy of adults with chronic kidney infection Kumar Jeetendra | May 1, 2021 Today, the U.S. Food and Drug Administration accepted Farxiga (dapagliflozin) oral tablets to decrease the risk of kidney function decline, kidney failure, cardiovascular death and hospitalization for heart failure in adults with chronic kidney disease who are at risk of disease progression. Chronic kidney disease occurs when the kidneys are damaged and can’t filter blood …
Scientists breaking barriers to treating heart failure Kumar Jeetendra | February 8, 2022 Ceryx Medical Limited, together with scientists at the Auckland Bioengineering Institute (ABI) and the Universities of Bath and Bristol, has developed technology that could radically improve the outlook for patients with serious heart conditions. Ceryx’s co-founder Julian Paton, Professor of Translational Physiology at ABI, began studying the relationship between the heartbeat and respiration more than …
